Peter Makhov

1.7k total citations · 1 hit paper
34 papers, 1.3k citations indexed

About

Peter Makhov is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peter Makhov has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Peter Makhov's work include Trace Elements in Health (8 papers), Renal cell carcinoma treatment (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Peter Makhov is often cited by papers focused on Trace Elements in Health (8 papers), Renal cell carcinoma treatment (6 papers) and Cancer, Lipids, and Metabolism (6 papers). Peter Makhov collaborates with scholars based in United States, Russia and Italy. Peter Makhov's co-authors include Vladimir Kolenko, Robert G. Uzzo, Alexander Kutikov, Konstantin Golovine, Shreyas Joshi, Pooja Ghatalia, Daniel Canter, Paul L. Crispen, Ervin Teper and Alexei V. Tulin and has published in prestigious journals such as Oncogene, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Peter Makhov

34 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies

2018 359 citations Peter Makhov, Alexander Kutikov et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Makhov United States	19	712	433	307	290	213	34	1.3k
Konstantin Golovine United States	19	481 0.7×	162 0.4×	184 0.6×	183 0.6×	261 1.2×	26	1.0k
Aya Naiki‐Ito Japan	25	870 1.2×	283 0.7×	279 0.9×	245 0.8×	65 0.3×	99	1.7k
Vasundara Venkateswaran Canada	22	535 0.8×	510 1.2×	330 1.1×	176 0.6×	52 0.2×	47	1.4k
Karine Mahéo France	22	723 1.0×	112 0.3×	378 1.2×	162 0.6×	108 0.5×	40	1.4k
Katalin Jemnitz Hungary	17	379 0.5×	152 0.4×	135 0.4×	409 1.4×	281 1.3×	50	1.2k
Hongfei Wu China	24	1.0k 1.5×	211 0.5×	639 2.1×	211 0.7×	99 0.5×	92	1.8k
Lakshmipathi Khandrika United States	10	719 1.0×	189 0.4×	301 1.0×	190 0.7×	42 0.2×	19	1.4k
Sakthivel Muniyan United States	23	656 0.9×	164 0.4×	120 0.4×	230 0.8×	88 0.4×	53	1.2k
Serena Marchetti Netherlands	19	577 0.8×	144 0.3×	107 0.3×	836 2.9×	155 0.7×	48	1.4k
Fabrizio Fontana Italy	27	920 1.3×	192 0.4×	417 1.4×	387 1.3×	47 0.2×	46	1.8k

Countries citing papers authored by Peter Makhov

Since Specialization

Citations

This map shows the geographic impact of Peter Makhov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Makhov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Makhov more than expected).

Fields of papers citing papers by Peter Makhov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Makhov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Makhov. The network helps show where Peter Makhov may publish in the future.

Co-authorship network of co-authors of Peter Makhov

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Makhov. A scholar is included among the top collaborators of Peter Makhov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Makhov. Peter Makhov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Makhov, Peter, et al.. (2024). Targeting NPC1 in Renal Cell Carcinoma. Cancers. 16(3). 517–517. 1 indexed citations

Tsimafeyeu, Ilya, et al.. (2024). A novel anti-FGFR1 monoclonal antibody OM-RCA-01 exhibits potent antitumor activity and enhances the efficacy of immune checkpoint inhibitors in lung cancer models. Immuno-Oncology Technology. 23. 100725–100725. 4 indexed citations

Makhov, Peter, et al.. (2022). Examining the Effect of PARP-1 Inhibitors on Transcriptional Activity of Androgen Receptor in Prostate Cancer Cells. Methods in molecular biology. 2609. 329–335. 4 indexed citations

Makhov, Peter, Ji A. Sohn, Ilya G. Serebriiskii, et al.. (2020). CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma. British Journal of Cancer. 123(12). 1749–1756. 19 indexed citations

Makhov, Peter, Sei Naito, Miki Haifler, et al.. (2018). The convergent roles of NF-κB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma. Cell Death and Disease. 9(3). 374–374. 40 indexed citations

Makhov, Peter, Sei Naito, & Vladimir Kolenko. (2017). Testing PARP Inhibitors Using a Murine Xenograft Model. Methods in molecular biology. 1608. 313–320. 2 indexed citations

Naito, Sei, Peter Makhov, Igor Astsaturov, et al.. (2017). LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma. British Journal of Cancer. 116(9). 1203–1207. 29 indexed citations

Thomas, Colin, Yingbiao Ji, Niraj Lodhi, et al.. (2016). Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo. EBioMedicine. 13. 90–98. 36 indexed citations

Golovine, Konstantin, Peter Makhov, Sei Naito, et al.. (2015). Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma. Cancer Biology & Therapy. 16(5). 743–749. 33 indexed citations

10.

Makhov, Peter, Konstantin Golovine, Ervin Teper, et al.. (2014). Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. British Journal of Cancer. 110(4). 899–907. 103 indexed citations

11.

Teper, Ervin, Peter Makhov, Konstantin Golovine, et al.. (2012). The Effect of 5-Aminolevulinic Acid and Its Derivatives on Protoporphyrin IX Accumulation and Apoptotic Cell Death in Castrate-resistant Prostate Cancer Cells. Urology. 80(6). 1391.e1–1391.e7. 7 indexed citations

12.

Golovine, Konstantin, Peter Makhov, Ervin Teper, et al.. (2012). Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. The Prostate. 73(1). 23–30. 57 indexed citations

13.

Kutikov, Alexander, Peter Makhov, Konstantin Golovine, et al.. (2011). Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer. Urology. 78(4). 968.e7–968.e11. 20 indexed citations

14.

Makhov, Peter, Alexander Kutikov, Konstantin Golovine, et al.. (2011). Docetaxel‐mediated apoptosis in myeloid progenitor TF‐1 cells is mitigated by zinc: Potential implication for prostate cancer therapy. The Prostate. 71(13). 1413–1419. 14 indexed citations

15.

Makhov, Peter, Konstantin Golovine, Alexander Kutikov, et al.. (2011). Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis. 32(12). 1773–1781. 21 indexed citations

16.

Golovine, Konstantin, Peter Makhov, Robert G. Uzzo, et al.. (2010). Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-κB-independent, proteasome-mediated mechanism. Molecular Cancer. 9(1). 183–183. 25 indexed citations

17.

Golovine, Konstantin, Robert G. Uzzo, Peter Makhov, et al.. (2008). Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL‐6 and IL‐8 in prostate cancer cells via NF‐κB‐dependent pathway. The Prostate. 68(13). 1443–1449. 61 indexed citations

18.

Makhov, Peter, Konstantin Golovine, Robert G. Uzzo, et al.. (2008). Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Cell Death and Differentiation. 15(11). 1745–1751. 62 indexed citations

19.

Crispen, Paul L., Robert G. Uzzo, Konstantin Golovine, et al.. (2007). Vitamin E succinate inhibits NF‐κB and prevents the development of a metastatic phenotype in prostate cancer cells: Implications for chemoprevention. The Prostate. 67(6). 582–590. 46 indexed citations

20.

Yamaguchi, Kenya, Robert G. Uzzo, Julia Pimkina, et al.. (2005). Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Oncogene. 24(38). 5868–5877. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact